Snowden Capital Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,645
Closed -$223K 1141
2022
Q1
$223K Buy
6,645
+6,267
+1,658% +$206K 0.01% 936
2021
Q4
$12K Buy
+378
New +$12.4K ﹤0.01% 1470

Other funds holding FMS

Snowden Capital Advisors's FMS Position: Q2 2022 in Review

Snowden Capital Advisors sold out of Fresenius Medical Care (FMS) in Q2 2022, closing a stake of 6,645 shares — an estimated $223K sold.

Snowden Capital Advisors first reported a position in FMS in Q4 2021 and held it in 2 quarters. The position peaked at $223K in Q1 2022. 166 funds tracked by Wall St. Rank hold FMS as of Q2 2022.

  • Snowden Capital Advisors reported no remaining Fresenius Medical Care position as of Q2 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 6,645 Fresenius Medical Care shares in Q2 2022, an estimated $223K.
  • Snowden Capital Advisors first reported a position in Fresenius Medical Care in Q4 2021 and held it in 2 quarters.
  • Snowden Capital Advisors's Fresenius Medical Care position peaked at $223K in Q1 2022.
  • 166 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2022.

Based on Snowden Capital Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.